SIGA Technologies, Inc. (SIGA)

Market Cap	335.67M -13.6%
Revenue (ttm)	93.78M -22.1%
Net Income	20.23M -58.3%
EPS	0.28 -58.3%
Shares Out	71.72M
PE Ratio	16.72
Forward PE	31.20
Dividend	$0.60 (12.82%)
Ex-Dividend Date	Apr 7, 2026

Volume	602,599
Open	4.680
Previous Close	4.710
Day's Range	4.650 - 4.800
52-Week Range	4.095 - 9.620
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	May 7, 2026

About SIGA

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company’s lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Sep 9, 1997
• Employees: 49
• Stock Exchange: NASDAQ
• Ticker Symbol: SIGA
• Website: https://www.siga.com

Financial Performance

In 2025, SIGA Technologies's revenue was $94.57 million, a decrease of -31.82% compared to the previous year's $138.72 million. Earnings were $23.28 million, a decrease of -60.69%.